Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates an updated version of the page in the site's content management system.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small release update to the page's documentation/versioning without visible changes to study details.
    Difference
    0.0%
    Check dated 2026-08-09T09:26:57.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.4), indicating a minor update to the page's documentation/system version.
    Difference
    0.0%
    Check dated 2026-07-25T17:58:43.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The Revision field was updated from v3.6.2 to v3.6.3, signaling a minor page update. This change does not modify the visible content or functionality of the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:15:55.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, signaling a backend update to the ClinicalTrials.gov record. This change does not appear to alter study text or visible content.
    Difference
    0.0%
    Check dated 2026-06-27T05:55:01.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Added recruitment status indicating the study is no longer enrolling. Also added new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated header formatting with a new revision tag (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T00:23:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.